Biotron Share Price Competition Jan 1 2022, page-113

I just read this and it reminded me so much of Biotron, patience is the key!
Hopefully it doesn't get moderated as OT, because we are talking about delays in both companies and that is relevant just as much here.

IDT Australia -September update
It takes a special kind of investor (some would say crazy) to invest in biotech companies. Extreme patience is required as the timelines for progress are often measured in years. In dispersed with this can be brief periods where the ground can shift under you surprisingly rapidly.
Many long-term IDT Australia investors would understand this all too well. After what many would call IDT’s “lost decade”, the last few months are proving that fortunes can turn around in a flash.